Cogent Biosciences COGT
NASDAQ COGT
$31.65 -0.01 (-0.03%)
As of: Sep 30, 2026 · 9:59 AM EDT

Cogent Biosciences (COGT) Total Current Liabilities (2017 - 2026)

Updated

Cogent Biosciences' Total Current Liabilities was $59.3 million in Q2 2026, up 1.5% from $58.42 million a year earlier and up 2.3% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Cogent Biosciences came in at $63.95 million, up 14.8% from FY2024.

  • Total Current Liabilities has now increased for five consecutive years, with a five-year compound annual growth rate of 37.3% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $55.71 million in FY2024 (+46.0%), $38.17 million in FY2023 (+42.2%), $26.85 million in FY2022 (+57.2%) and $17.08 million in FY2021 (+30.4%).
  • Quarterly Total Current Liabilities has moved between $16.71 million (Q3 2021) and $63.95 million (Q4 2025) over five years.
  • Compared with a year earlier, Total Current Liabilities has increased for 12 straight quarters, with growth averaging 28.8% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q1 2022 (growth of 116.9%); the worst was Q3 2021 (a decline of 17.0%).
  • Per Business Quant data, COGT's Total Current Liabilities in the three quarters before Q2 2026 was $57.98 million (Q1 2026), $63.95 million (Q4 2025) and $62.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Cogent Biosciences 5.47 Bn 5.47 Bn - 59.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.30 Mn
Mar 31, 2026 57.98 Mn
Dec 31, 2025 63.95 Mn
Sep 30, 2025 62.25 Mn
Jun 30, 2025 58.42 Mn
Mar 31, 2025 49.32 Mn
Dec 31, 2024 55.71 Mn
Sep 30, 2024 53.05 Mn
Jun 30, 2024 40.00 Mn
Mar 31, 2024 36.69 Mn
Dec 31, 2023 38.17 Mn
Sep 30, 2023 34.72 Mn
Jun 30, 2023 25.76 Mn
Mar 31, 2023 21.12 Mn
Dec 31, 2022 26.85 Mn
Sep 30, 2022 23.55 Mn
Jun 30, 2022 27.66 Mn
Mar 31, 2022 17.88 Mn
Dec 31, 2021 17.08 Mn
Sep 30, 2021 16.71 Mn
API Access

Cogent Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=COGT&period=max&api_key=YOUR_API_KEY